Summary.
The observation of many cases of mumps and mumps-associated CNS complications in vaccinees prompted us to perform an evaluation of the efficacy of four attenuated mumps virus (Urabe, Jeryl Lynn, Rubini and S12) vaccines. Two doses of vaccine were necessary to induce a good immunity in animals. The humoral and cell-mediated response induced in mice immunized intramuscularly or intranasally with these vaccines has been evaluated. Although the Urabe and Jeryl Lynn strains appear more immunogenic than the other strains and induce higher levels of IgG when administered intramuscularly, the S-12 strain administered intranasally induces a good IgG response. A marked specific CTL activity against mumps virus was observed in mice immunized intranasally with all the strains and, particularly, with the S12 strain. Thus, the intranasal immunization could be considered a possible alternative and efficient route of vaccination against mumps.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received October 30, 2000 Accepted March 17, 2001
Rights and permissions
About this article
Cite this article
Cusi, M., Correale, P., Valassina, M. et al. Comparative study of the immune response in mice immunized with four live attenuated strains of mumps virus by intranasal or intramuscular route. Arch. Virol. 146, 1241–1248 (2001). https://doi.org/10.1007/s007050170088
Issue Date:
DOI: https://doi.org/10.1007/s007050170088